Dr. Reddy's Labs Files 6-K with SEC
Ticker: RDY · Form: 6-K · Filed: Aug 11, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, routine-update
TL;DR
DRL files routine 6-K, confirms 20-F reporting, based in India.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 11, 2025, indicating it is a foreign private issuer submitting its annual reports under Form 20-F. The filing provides updated contact and company information from its principal executive office located in Hyderabad, Telangana, India.
Why It Matters
This filing is a routine update for foreign private issuers, confirming their reporting status and providing essential company contact information to the SEC and investors.
Risk Assessment
Risk Level: low — This is a standard procedural filing for a foreign private issuer and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- SEC (company) — Regulatory body
- Hyderabad, Telangana, India (location) — Principal executive office location
FAQ
What is the purpose of a Form 6-K filing for Dr. Reddy's Laboratories Ltd.?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company may be required to disclose or may make public in its home country.
Which annual report form does Dr. Reddy's Laboratories Ltd. file?
Dr. Reddy's Laboratories Ltd. files its annual reports under cover of Form 20-F.
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of August 11, 2025.
What is the Commission File Number for Dr. Reddy's Laboratories Ltd.?
The Commission File Number is 1-15182.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-08-11 08:29:17
Filing Documents
- rdy0792_6k.htm (6-K) — 52KB
- rdy0792_ex99-1.htm (EX-99.1) — 23KB
- rdy0792_ex99-1img01.jpg (GRAPHIC) — 3KB
- rdy0792_ex99-1img02.jpg (GRAPHIC) — 8KB
- 0001575872-25-000530.txt ( ) — 91KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: August 8, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3